Because of the discrepancy in the literature, Kapinas et al. wanted to devise the role of osteonectin in prostate cancer bone metastases using mineralized matrices produced by osteonectin-null and wild-type prostate cancer cells [152]. The gene discussed is SPARC; the disease is prostate cancer.